<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Major Shrinkage: Q220 Advanced Wound Care Market Recap

9/23/20 9:00 AM

Q220 AWC HeaderIn Q220, all geographies experienced shrinkage in their AWC revenues with Single-use NPWT showing the sharpest declines.

All companies are experiencing a negative impact on their wound businesses from COVID-19 in Q220, but most are also stating that June was better than April, indicating a strong recovery in the wound market. 3M* remains the WW market leader with Q220 revenue down -14.9% YoY. WW Advanced Dressings declined -9.9%, impacted by COVID-19, especially in hospitals. US Skin/Dermal Substitute (CTP) revenue fell also, with mixed results from market leaders. WW NPWT was down -17.8%, with single-use and traditional devices down -24.2% and -16.4%, respectively.


Among the many topics covered in the comprehensive Q220 Advanced Wound Care Market Recap* are:

  • Complete Market Overview with Company Revenues and Shares
  • Impact of COVID-19 on Q220 Market Leaders
  • Wound Biologics – Mixed Results
  • NPWT – COVID-19 Creates Negative Pressure on NPWT Devices
  • Advanced Dressings – Limited COVID-19 Impact
  • Detailed Growth Analysis
  • Q220 Growth in Constant and Reported in Key Companies
  • Other Notable Happenings in Q220 AWC Market

All companies tracked showed negative organic growth in the quarter. Smith+Nephew* saw the greatest impact, with its business largely focused on hospitals. Coloplast and Mölnlycke performed better, with businesses more focused on home care, especially in Europe. Hartmann* declined as their traditional wound range was ...

Read the entire Q220 Advanced Wound Care Market Recap including news, data, charts, company revenues and analysis*

*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.

Learn More

 

Susan Paquette
Written by Susan Paquette

Susan Paquette, MS, MBA | Vice President and General Manager, Wound. 25+ years' experience in new business development, R&D, international and marketing. Director, New Business Development & Commercialization, 3M Health Care; Technical Director, 3M Medical.

    Recent Articles